EIF2AK3 and myeloid sarcoma: Using genetic approaches, the studies described above well-documented the cytoprotective effects of the PERK-eIF2α pathway on both mature and remyelinating oligodendrocytes in mouse models of MS (Lin et al., 2013, 2014a; Hussien et al., 2014).